Efficacy study of carboplastin/TS-1 during postoperative adjuvant chemotherapy after complete resection of non-small cell lung cancer at pathological stage II and IIIA in elderly patients older than 75 years old
Latest Information Update: 27 Jul 2022
At a glance
- Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms Escargo002; Escargot 002
- 24 Jul 2022 According to UMIN record, Date of closure to data entry is 1 Jul 2022, Date trial data considered complete is 1 May 2023 and Date analysis concluded is 31 Dec 2023.
- 13 Sep 2018 Status changed from recruiting to completed.
- 16 Aug 2013 New trial record